Skip to content

Comparison of Therapeutic Effects of Trigger Point Injection and Twin Nerve Block in Chronic Myofascial Pain Patients

Comparison of Therapeutic Effects of Trigger Point Injection and Twin Nerve Block in Chronic Myofascial Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03870191
Enrollment
48
Registered
2019-03-12
Start date
2016-06-21
Completion date
2020-05-31
Last updated
2020-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain - Dysfunction Syndrome of TMJ, Nerve Block, Trigger Point Pain, Myofascial

Brief summary

To see if there is there any difference in the treatment outcomes/results such as changes in pain intensity in patients with myofascial pain who have been treated with trigger point injections or twin block?

Detailed description

Most treatment approaches for chronic myofascial pain are not evidence-based. Studies are usually controversial. Most are short-term, non-randomized. An essential limitation has been the lack of standardization of diagnosis. Some studies do not differentiate between joint pain and muscle pain, which can significantly affect the outcome of the treatment provided. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) was recently published and validated. Their protocol allows standardization of the assessment and diagnosis of patients with temporomandibular disorder, including myofascial pain. To the investigator's knowledge, no previous prospective, randomized study has been conducted demonstrating the treatment outcomes of either trigger point injections or twin block in patients with chronic myofascial pain.

Interventions

OTHERInjection of either twin block or trigger point injection.

Study participants will be randomized into either group and will receive the intervention.

Sponsors

Rutgers University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with Myofascial pain with referral based on the DC/TMD criteria * Pain on the masseter and or temporalis muscles * Pain present for at least 3 months

Exclusion criteria

* Generalized muscle disorder such as fibromyalgia * Subjects on chronic pain medication * Subjects who are known to have hypersensitivity to the local anesthetics. * Pregnant women. A pregnancy test will not be given before subject enrollment. Women of childbearing ages will be asked verbally if they are pregnant. If they are unsure, then they will be excluded from the study. * Subjects with cognitive problems e.g. Alzheimer's disease.

Design outcomes

Primary

MeasureTime frameDescription
Pain relief: numerical pain scale6 monthsThe pain relief received from each injection will be measured using the numerical pain scale. This scale is between 0-10 with 0 meaning no pain and 10 is the most pain.Higher values represent worse pain.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026